Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation (SCT)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00266136
What this trial is testing

Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG)

Who this might be right for
Acute Myeloid Leukemia
University Hospital Muenster 3,500
Not applicableUnknownNCT02981199
What this trial is testing

Microtransplantation Versus Auto-SCT in ≥PR Multiple Myeloma Patients

Who this might be right for
MicrotransplantationAutologous Stem Cell TransplantationMultiple Myeloma in Relapse
Chen Wenming 80
Not applicableUnknownNCT05905770
What this trial is testing

Do Alemtuzumab Levels Predict T Cell Chimerism After MSD SCT for SCD?

Who this might be right for
Sickle Cell Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 20
Testing effectiveness (Phase 2)Ended earlyNCT02504619
What this trial is testing

Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies

Who this might be right for
Sickle Cell DiseaseThalassemia
Gamida Cell ltd 1
Testing effectiveness (Phase 2)Study completedNCT01590628
What this trial is testing

Allogeneic SCT of NiCord®, UCB-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies

Who this might be right for
Sickle Cell Disease & Thalassemia
Gamida Cell ltd 16
Testing effectiveness (Phase 2)Study completedNCT00578942
What this trial is testing

Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath

Who this might be right for
LymphomaMyelomaLeukemia+2 more
David Rizzieri, MD 48
Not applicableStudy completedNCT03204721
What this trial is testing

Prevention of GVHD in Patients Treated With Allogeneic SCT: Possible Role of Extracorporeal Photophoresis

Who this might be right for
Graft-Versus-Host Disease
Oslo University Hospital 158
Not applicableStudy completedNCT04386928
What this trial is testing

ALLO-SCT in Elderly Patients With Hematological Disease

Who this might be right for
Hematologic DiseasesStem Cell Transplant Complications
Gruppo Italiano Trapianto di Midollo Osseo 1,996
Large-scale testing (Phase 3)UnknownNCT00002989
What this trial is testing

Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
European Organisation for Research and Treatment of Cancer - EORTC 207
Early research (Phase 1)WithdrawnNCT00062543
What this trial is testing

Hepatic Artery Infusion of CD34+ Cells

Who this might be right for
Stem Cell TransplantationLiver Diseases
M.D. Anderson Cancer Center
Not applicableStudy completedNCT00579917
What this trial is testing

Behavioral Intervention For BMT/SCT Survivors

Who this might be right for
Hodgkin's DiseaseLeukemiaMultiple Myeloma+1 more
Memorial Sloan Kettering Cancer Center 133
Testing effectiveness (Phase 2)WithdrawnNCT02701673
What this trial is testing

Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00330018
What this trial is testing

Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT)

Who this might be right for
Bone Marrow TransplantationCytomegalovirus
Hadassah Medical Organization 40
Testing effectiveness (Phase 2)Study completedNCT02258815
What this trial is testing

CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed Neuroblastoma

Who this might be right for
Neuroblastoma Recurrent
University Children's Hospital Tuebingen 35
Early research (Phase 1)Study completedNCT04473911
What this trial is testing

Haplo Peripheral Blood Sct In GVHD Prevention

Who this might be right for
GVHDAMLALL+13 more
Zachariah Michael DeFilipp 25
Large-scale testing (Phase 3)Ended earlyNCT03391856
What this trial is testing

Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive Therapy

Who this might be right for
ThrombocytopeniaStem Cell Transplant Complications
Peking University People's Hospital 15
Testing effectiveness (Phase 2)UnknownNCT03454984
What this trial is testing

SGI-110 and Donor Lymphocyte Infusions (DLI) After Allogeneic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Groupe Francophone des Myelodysplasies 40
Not applicableLooking for participantsNCT02438904
What this trial is testing

Compassionate Access of the Miltenyi Device for CD34+ Cell Selection

Who this might be right for
Blood And Marrow Transplantation
M.D. Anderson Cancer Center 200
Not applicableStudy completedNCT00386373
What this trial is testing

Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)UnknownNCT01513109
What this trial is testing

Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia

Who this might be right for
Acute Myelogenous LeukemiaMyeloid Leukemia in RemissionEffects of Immunotherapy
Jules Bordet Institute 20
Next Page